Abstract
Screvo BV is an early-stage biotech company founded in 2012 whose mission is to optimize the number of experimental animals in preclinical research. It is a spin-off from the Tissue Regeneration department of the MIRA Institute for Biomedical Technology of the University Twente, The Netherlands. Screvo’s first product, Vers3D, is an implantable well system that can be used in a wide variety of in vitro and in vivo applications. By increasing the number of conditions simultaneously screened in one animal, animal testing of drugs and treatments is at least three times more time-efficient and at least nine times more cost-effective thanks to this exciting new product.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Higuera, J. (2018). Screvo: 3D Screening Devices for In Vitro and In Vivo Applications. In: Peña Dopazo, J., Zivic, F. (eds) Supporting University Ventures in Nanotechnology, Biomaterials and Magnetic Sensing Applications. Springer, Cham. https://doi.org/10.1007/978-3-319-61237-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-61237-9_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61236-2
Online ISBN: 978-3-319-61237-9
eBook Packages: EngineeringEngineering (R0)